KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Exchange Rate Effect: 2017-2025

Historic Exchange Rate Effect for Elanco Animal Health (ELAN) over the last 9 years, with Sep 2025 value amounting to $1.0 million.

  • Elanco Animal Health's Exchange Rate Effect fell 87.50% to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$20.0 million, marking a year-over-year decrease of 17.65%. This contributed to the annual value of -$91.0 million for FY2024, which is 658.33% down from last year.
  • Per Elanco Animal Health's latest filing, its Exchange Rate Effect stood at $1.0 million for Q3 2025, which was down 96.30% from $27.0 million recorded in Q2 2025.
  • In the past 5 years, Elanco Animal Health's Exchange Rate Effect ranged from a high of $32.0 million in Q4 2022 and a low of -$77.0 million during Q4 2024.
  • For the 3-year period, Elanco Animal Health's Exchange Rate Effect averaged around -$4.6 million, with its median value being -$2.0 million (2023).
  • As far as peak fluctuations go, Elanco Animal Health's Exchange Rate Effect tumbled by 1,800.00% in 2024, and later soared by 1,000.00% in 2025.
  • Over the past 5 years, Elanco Animal Health's Exchange Rate Effect (MRQ) stood at -$8.0 million in 2021, then soared by 500.00% to $32.0 million in 2022, then plummeted by 109.38% to -$3.0 million in 2023, then plummeted by 2,466.67% to -$77.0 million in 2024, then soared by 101.30% to $1.0 million in 2025.
  • Its last three reported values are $1.0 million in Q3 2025, $27.0 million for Q2 2025, and $29.0 million during Q1 2025.